The antiinfective medicine sales in Chile showed significant fluctuations over the past decade. In 2023, the sales stood at 414.01 billion Chilean Pesos. From 2013 to 2023, year-on-year variations were notable, with the highest growth seen in 2013 (58.74%) and the most considerable decline in 2021 (-28.25%). The five-year CAGR was most substantial in 2015 (32.7%) and dropped to 2.3% by 2023.
Future trends to watch for include:
- Increasing demand for innovative antiinfective treatments.
- Government policies impacting drug pricing and accessibility.
- Technological advancements in drug formulation and delivery.
- Global health trends affecting local consumption patterns.
